
CBB3001
CAS No. 1639358-50-1
CBB3001( CBB-3001 | CBB 3001 )
Catalog No. M12479 CAS No. 1639358-50-1
CBB3001 (CBB-3001) is a novel potent, selective histone demethylase LSD1 inhibitor with IC50 of 21.25 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 1053 | Get Quote |
![]() ![]() |
50MG | 2142 | Get Quote |
![]() ![]() |
100MG | 2790 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCBB3001
-
NoteResearch use only, not for human use.
-
Brief DescriptionCBB3001 (CBB-3001) is a novel potent, selective histone demethylase LSD1 inhibitor with IC50 of 21.25 uM.
-
DescriptionCBB3001 (CBB-3001) is a novel potent, selective histone demethylase LSD1 inhibitor with IC50 of 21.25 uM; potently inhibits LSD1 activity both in vitro and in vivo; CBB3001 also selectively inhibits the growth of human ovarian teratocarcinoma PA-1 and mouse embryonic carcinoma F9 cells, caused the downregulation of pluripotent stem cell proteins SOX2 and OCT4, does not have significant inhibition on the growth of human colorectal carcinoma HCT116 cells or mouse fibroblast NIH3T3 cells that do not express these stem cell proteins.
-
In Vitro——
-
In Vivo——
-
SynonymsCBB-3001 | CBB 3001
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHistone Demethylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1639358-50-1
-
Formula Weight349.427
-
Molecular FormulaC19H27NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)OC(=O)NC1CC1C2=CC=C(C=C2)OC(=O)OC(C)(C)C
-
Chemical Nametert-butyl 2-(4-(tert-butoxycarbonyloxy)phenyl)cyclopropylcarbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hoang N, et al. Bioorg Med Chem. 2018 May 1;26(8):1523-1537.
molnova catalog



related products
-
YF-2
YF-2 is blood-brain-barrier permeable histone acetyltransferase activator acetylates H3 in the hippocampus ?CBP PCAF and GCN5 with EC50s of 2.75 μM 29.04 μM and 49.31 μM respectively.
-
LSD1-IN-30
LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.
-
PFI-90
PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action.PFI-90 has the potential for the antitumor activity.